GIPC1 and colorectal cancer: We found similar losses of cell viability and increased caspase 3/7 activities after GIPC1 silencing in the MCF-7 and SKBR-3 human breast cancer and SW480 and SW620 human colorectal cancer cell lines (data not shown).